Noninvasive genomic detection of melanoma

British Journal of Dermatology

Volumn 164, Issue 4, 2011, Pages 797-806

  Wachsman, William ^a,b   Morhenn, V ^c,d   Palmer, T ^e   Walls, L ^a,b   Hata, T ^c   Zalla, J ^f   Scheinberg, R ^g   Sofen, H ^h   Mraz, S ⁱ   Gross, K ^j   Rabinovitz, H ^k   Polsky, D ^l   Chang, S ^e  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Therapeutics Clinical Research   (United States)

^e DermTech International   (United States)

^f Dermatology Associates   (United States)

^g Dermatologist Medical Group   (United States)

^h Dermatology Associates   (United States)

ⁱ Solano Dermatology Associates   (United States)

^j Skin Surgery Medical Group   (United States)

^k SKIN AND CANCER ASSOCIATES   (United States)

^l NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CELL FUNCTION; CELL GROWTH; CELL MATURATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EPIDERMAL GENETIC INFORMATION RETRIEVAL; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ANALYSIS; GENOMICS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MELANOCYTE; MELANOMA; MICROARRAY ANALYSIS; NEVUS; PRIORITY JOURNAL; RNA ISOLATION; STRATUM CORNEUM;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; DIAGNOSIS, DIFFERENTIAL; EARLY DIAGNOSIS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MELANOMA; MICROARRAY ANALYSIS; MIDDLE AGED; NEVUS; RNA; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; SURGICAL TAPE;

EID: 79953695637     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10239.x     Document Type: Article

References (38)

1. Lens MB, Dawes M. Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol 2004; 150:179-85. (Pubitemid 38352453)
2. Altekruse SF, Kosary CL, Krapcho M et al. SEER Cancer Statistics Review, 1975-2007. Bethesda, MD: National Cancer Institute, 2010.
3. Minor DR, Moore D, Kim C et al. Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy. Oncologist 2009; 14:995-1002.
4. Goldsmith LA, Askin FB, Chang AE et al. Diagnosis and treatment of early melanoma: NIH Consensus Development Panel on Early Melanoma. JAMA 1992; 268:1314-19.
5. Balch CM, Gershenwald JE, Soong SJ et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009; 27:6199-206.
6. Cassileth BR, Clark WH Jr, Lusk EJ et al. How well do physicians recognize melanoma and other problem lesions? J Am Acad Dermatol 1986; 14:555-60.
7. Osborne JE, Chave TA, Hutchinson PE. Comparison of diagnostic accuracy for cutaneous malignant melanoma between general dermatology, plastic surgery and pigmented lesion clinics. Br J Dermatol 2003; 148:252-8. (Pubitemid 36278965)
8. Carli P, Nardini P, Crocetti E et al. Frequency and characteristics of melanomas missed at a pigmented lesion clinic: a registry-based study. Melanoma Res 2004; 14:403-7. (Pubitemid 39431237)
9. Marks R, Jolley D, McCormack C, Dorevitch AP. Who removes pigmented skin lesions? J Am Acad Dermatol 1997; 36:721-6.
10. Binder M, Schwarz M, Winkler A et al. Epiluminescence microscopy. A useful tool for the diagnosis of pigmented skin lesions for formally trained dermatologists. Arch Dermatol 1995; 131:286-91.
11. Vestergaard M, Macaskill P, Holt P, Menzies SW. Dermoscopy compared to naked eye examination for the diagnosis of primary melanoma: a meta-analysis of studies performed in a clinical setting. Br J Dermatol 2008; 159:669-76.
12. Skvara H, Teban L, Fiebiger M et al. Limitations of dermoscopy in the recognition of melanoma. Arch Dermatol 2005; 141:155-60. (Pubitemid 40216257)
13. Tripp JM, Kopf AW, Marghoob AA, Bart RS. Management of dysplastic nevi: a survey of fellows of the American Academy of Dermatology. J Am Acad Dermatol 2002; 46:674-82.
14. Haenssle HA, Krueger U, Vente C et al. Results from an observational trial: digital epiluminescence microscopy increases the sensitivity and the chance of success of conventional dermoscopy in detecting melanoma. J Invest Dermatol 2006; 126:980-5.
15. Marghoob AA, Swindle LD, Moricz CZ et al. Instruments and new technologies for the in vivo diagnosis of melanoma. J Am Acad Dermatol 2003; 49:777-97. (Pubitemid 37314865)
16. Menzies SW. Cutaneous melanoma: making a clinical diagnosis, present and future. Dermatol Ther 2006; 19:32-9.
17. Vestergaad M, Menzies SW. Automated diagnostic instruments for cutaneous melanoma. Semin Cutan Med Surg 2008; 27:32-6. (Pubitemid 351662751)
18. Guitera P, Pellacani G, Longo C et al. In vivo confocal microscopy enhances secondary evaluation of melanocytic lesions. J Invest Dermatol 2009; 129:131-8.
19. McGinnis KS, Lessin SR, Elder DE et al. Pathology review of cases presenting to a multidisciplinary pigmented lesion clinic. Arch Dermatol 2002; 138:617-21.
20. Ferrara G, Argenyi Z, Argenziano G et al. The influence of clinical information in the histopathologic diagnosis of melanocytic skin neoplasms. PLoS ONE 2009; 4:e5375.
21. Morhenn VB, Chang EY, Rheins LA. A non-invasive method for quantifying and distinguishing inflammatory skin reactions. J Am Acad Dermatol 1999; 41:687-92. (Pubitemid 29514022)
22. Wong R, Tran V, Morhenn VB et al. Use of RT-PCR and DNA microarrays to characterize RNA recovered by non-invasive tape harvesting of normal and inflamed skin. J Invest Dermatol 2004; 123:159-67. (Pubitemid 38833477)
23. Benson NR, Papenfuss J, Wong R et al. An analysis of select pathogenic messages in lesional and non-lesional psoriatic skin using non-invasive tape harvesting. J Invest Dermatol 2006; 126:2234-41. (Pubitemid 44413170)
24. Westfall PH, Young SS. Resampling-Based Multiple Testing: Examples and Methods for P-value Adjustment. New York: Wiley, 1993.
25. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998; 95:14863-8. (Pubitemid 29003722)
26. Tamayo P, Slonim D, Mesirov J et al. Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. Proc Natl Acad Sci USA 1999; 96:2907-12. (Pubitemid 29148817)
27. Friedman JH. Greedy function approximation: a gradient boosting machine. Ann Stat 2001; 29:1189-232. (Pubitemid 33405972)
28. Friedman JH. Stochastic gradient boosting. Comput Stat Data Anal 2002; 38:367-78. (Pubitemid 34197167)
29. Lu KH, Patterson AP, Wang L et al. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis. Clin Cancer Res 2004; 10:3291-300. (Pubitemid 38685433)
30. Naderi A, Teschendorff AE, Beigel J et al. BEX2 is overexpressed in a subset of primary breast cancers and mediates nerve growth factor/nuclear factor-kappaB inhibition of apoptosis in breast cancer cell lines. Cancer Res 2007; 67:6725-36. (Pubitemid 47105519)
31. Berger Y, Bernasconi CC, Juillerat-Jeanneret L. Targeting the endothelin axis in human melanoma: combination of endothelin receptor antagonism and alkylating agents. Exp Biol Med 2006; 231:1111-19. (Pubitemid 43845588)
32. Wyman K, Atkins MB, Prieto V et al. Multicenter phase II trial of high-dose imatinib mesylate in metastatic melanoma: significant toxicity with no clinical efficacy. Cancer 2006; 106:2005-11. (Pubitemid 43673217)
33. Nakajima TE, Yamada Y, Furuta K et al. Adiopokine levels and the risk of gastric cancer: a case-control study. J Clin Oncol 2008; 26 (Suppl.):4582 (Abstract).
34. Drochmans P. Etude au microscope électronique du mécanisme de la pigmentation mélanique. Arch Belg Dermatol Syphiligr 1960; 16:155-63.
35. Kubo A, Nagao K, Yokouchi M et al. External antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriers. J Exp Med 2009; 206:2937-46.
36. Torres-Cabala CA, Wang WL, Trent J et al. Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal type. Mod Pathol 2009; 22:1446-56.
37. Curtin JA, Fridlyand J, Kageshita T et al. Distinct sets of genetic alterations in melanoma. N Engl J Med 2005; 353:2135-47. (Pubitemid 41653105)
38. Maldonado JL, Fridlyand J, Patel H et al. Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst 2003; 95:1878-90.